UNSPSC 51151900: Centrally acting skeletal muscle relaxants

This classification denotes a heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. they have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. they have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis.

UNSPSC 51151900 Centrally acting skeletal muscle relaxants is a Class code encompassing pharmaceutical products supplied through state and local cooperative purchasing networks. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary issuing body visible in recent activity, soliciting generic multi-source pharmaceuticals and over-the-counter (OTC) products for distribution across participating state and local government facilities. Suppliers are required to obtain current Good Manufacturing Practices (cGMP) certification and Drug Supply Chain Security Act (DSCSA) compliance, maintain contractual relationships with authorized wholesalers including AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC, and carry comprehensive insurance including workers' compensation, commercial general liability of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000. Submissions must include product information tied to specific National Drug Codes (NDC), SKUs, UPCs, generic descriptions, strength, dosage form, trade names, and packaging configurations, with pricing submitted in EDI-compatible format through the ePro procurement system. Evaluation criteria weight price competitiveness at 75 percent, fixed pricing at 10 percent, and compliance, EDI capability, and administrative fee agreement collectively at 15 percent.

MMCAP's RFP posted January 20, 2026 with responses due March 26, 2026 represents the recent state and local activity under this code, spanning Minnesota and Oregon participants. The contract term runs two years for new responders with optional MMCAP extensions, while incumbent vendors' terms extend through June 30, 2028. All products must be available in the marketplace by May 15, 2026, with effective contract dates of July 1, 2026. Vendors are subject to performance penalties ranging from $200 to $1,500 per violation for late reporting, missed onboarding timelines, or improper class-of-trade denials, and must pay a 3 percent administrative fee on all contract purchases. No specific set-aside or disadvantaged-enterprise restrictions are identified in available documentation. The RFP does not disclose specific award values or budget ranges.